OVERDOSAGE
Aranesp overdosage can cause hemoglobin levels above the desired level, which should be managed with discontinuation or reduction of Aranesp dosage and/or with phlebotomy, as clinically indicated [see Pharmacodynamics ]. Cases of severe hypertension have been observed following overdose with ESAs [see Warnings and Precautions].
|